BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4153705)

  • 1. Proceedings: Effect of chronic treatment with central stimulants on brain monoamines and some behavioural and physiological functions in rats, guinea pigs, and rabbits.
    Lewander T
    Psychopharmacol Bull; 1974 Jul; 10(3):11-2. PubMed ID: 4153705
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of chronic treatment with central stimulants on brain monoamines and some behavioral and physiological functions in rats, guinea pigs, and rabbits.
    Lewander T
    Adv Biochem Psychopharmacol; 1974; 12(0):221-39. PubMed ID: 4607740
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: The effects of depleting brain amines on the behavioural actions of gamma-hydroxybutyric acid.
    Benton DA; Rick JT; Taberner PV
    Br J Pharmacol; 1974 Nov; 52(3):437P-438P. PubMed ID: 4458857
    [No Abstract]   [Full Text] [Related]  

  • 4. Central pharmacological effects of long-term application of piracetam in rats.
    Felińska W; Bień E
    Pol J Pharmacol Pharm; 1991; 43(1):7-13. PubMed ID: 1771165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and neurochemical characteristics of stimulant-induced augmentation.
    Segal DS; Kuczenski R
    Psychopharmacol Bull; 1987; 23(3):417-24. PubMed ID: 2893420
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain monoamines and behavior.
    Seiden LS
    Psychopharmacol Bull; 1975 Apr; 11(2):60-1. PubMed ID: 806089
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical pharmacology of brain amine mechanisms.
    Breese GR
    Psychopharmacol Bull; 1975 Apr; 11(2):40-1. PubMed ID: 1135370
    [No Abstract]   [Full Text] [Related]  

  • 8. [The characteristics of the effect of tuftsin on the behavior and on the level of biogenic amines in the brain of rats with differing resistance to acoustic stress].
    Ismaĭlova KhIu; Semenova TP; Iskanderova MD; Fast AE
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1998; 48(6):1043-50. PubMed ID: 9929913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain monoamines and plasma corticosterone in stressed rats treated with dextroamphetamine or propranolol.
    Pericic D; Manev H; Boranic M; Poljak-Blazi M
    Biomed Pharmacother; 1982; 36(6-7):291-6. PubMed ID: 7183343
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of compounds structurally related to 5,6-dihydroxytryptamine on behavior and brain biogenic amines in the rat.
    Donelson AC; Manian AA; Maickel RP
    Res Commun Chem Pathol Pharmacol; 1982 Dec; 38(3):517-20. PubMed ID: 7163644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey.
    Chiueh CC; Markey SP; Burns RS; Johannessen JN; Jacobowitz DM; Kopin IJ
    Psychopharmacol Bull; 1984; 20(3):548-53. PubMed ID: 6332333
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in brain monoamine metabolism associated with CO2-induced amnesia in rats.
    Leonard BE; Rigter H
    Br J Pharmacol; 1973 Jun; 48(2):351P-352P. PubMed ID: 4739052
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of prolonged methamphetamine treatment and its withdrawal on behavior and brain monoamine metabolism in mice].
    Odo S; Nakazawa T; Toru M
    Seishin Shinkeigaku Zasshi; 1985; 87(3):155-75. PubMed ID: 4034796
    [No Abstract]   [Full Text] [Related]  

  • 16. Methadone exposure in utero: effects on brain biogenic amines and behavior.
    Rech RH; Lomuscio G; Algeri S
    Neurobehav Toxicol; 1980; 2(2):75-8. PubMed ID: 7197331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central mechanisms of fenfluramine and related anorectic drugs.
    Garattini S
    Jpn J Pharmacol; 1981; 31 Suppl():29P-35P. PubMed ID: 7035726
    [No Abstract]   [Full Text] [Related]  

  • 18. [Concentration of biogenic amines in the central and peripheral nervous systems of rats with portacaval shunts, and their changes following administration of pargyline and levodopa].
    Alsasua A; Arias J; López-Sánchez ML; Estébanez E; Arias JI; García de Jalón PD; Durán Sacristán H
    Arch Farmacol Toxicol; 1982 Aug; 8(2):83-92. PubMed ID: 7159104
    [No Abstract]   [Full Text] [Related]  

  • 19. [Content, release and absorption of biogenic amines in CNS structures of the rat under the influence of sultones (proceedings)].
    Christl A; Fischer HD; Franz E; Funk K; Keller G; Rudolph E; Ruhnke M
    Pharmazie; 1979; 34(5-6):300-1. PubMed ID: 515127
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of intracerebroventricularly administered octopamine, phenylethylamine and epinephrine on the central serotonergic system of the rat.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1982; 34(4):193-200. PubMed ID: 6820690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.